Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.
- NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_assertion description "[Here we report the identification of a secondary mutation in ALK, F1174L, as one cause of crizotinib resistance in a patient with an inflammatory myofibroblastic tumor (IMT) harboring a RANBP2-ALK translocation who progressed while on crizotinib therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.
- NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_assertion evidence source_evidence_literature NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.
- NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_assertion SIO_000772 21030459 NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.
- NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_assertion wasDerivedFrom befree-20150227 NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.
- NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_assertion wasGeneratedBy ECO_0000203 NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP665112.RADruK5RT1yCVL46KqhhjH14f0gFxszl77zXE4C8kj8HA130_provenance.